pharmaceutical investing FDA Approves SEYSARA (Sarecycline) for the Treatment of Moderate to Severe Acne
pharmaceutical investing Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy
FDA Approves Start of Innovative On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke by Diffusion Pharmaceuticals
pharmaceutical investing Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector
pharmaceutical investing EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
medical device investing Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
CUAI - Copper Intelligence Extensive Drilling Program Continues to Validate Significant Copper System at Butembo, Eastern DRC
Syntholene Completes Phase One of Effects Testing at Iceland Demonstration Facility, Advances to High-Power Operations
